+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biosimilar Interleukins Global Market Report 2020-30: COVID-19 Growth and Change

  • ID: 5230059
  • Report
  • December 2020
  • Region: Global
  • 200 pages
  • The Business Research Company

FEATURED COMPANIES

  • Bio-Thera Solutions
  • Gedeon Richter
  • MabPharm
  • MORE
Biosimilar Interleukins Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar interleukins market.

This report focuses on biosimilar interleukins market which is experiencing strong growth. The report gives a guide to the biosimilar interleukins market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the biosimilar interleukins? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Biosimilar Interleukins market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider biosimilar interleukins market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biosimilar interleukins market section of the report gives context. It compares the biosimilar interleukins market with other segments of the biosimilar interleukins market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biosimilar interleukins indicators comparison.
Scope

Markets Covered:
1)By Type: IL-17; IL-23; IL-1; IL-5; IL-6; Others;
2)By Application: Psoriasis; Psoriatic Arthritis; Rheumatoid Arthritis; Asthma; Inflammatory Bowel Disease (IBD); Others;
3)By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies; Clinics; Research Institutes;

Companies Mentioned: MabPharm; Gedeon Richter; Bio-Thera Solutions; Sorrento Therapeutics/MabTech; Sunshine Guojian Pharmaceutical

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bio-Thera Solutions
  • Gedeon Richter
  • MabPharm
  • MORE
1. Executive Summary

2. Biosimilar Interleukins Market Characteristics

3. Biosimilar Interleukins Market Size and Growth
3.1. Global Biosimilar Interleukins Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers of the Market
3.1.2. Restraints on the Market
3.2. Global Biosimilar Interleukins Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers of the Market
3.2.2. Restraints on the Market

4. Biosimilar Interleukins Market Segmentation
4.1. Global Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • IL-17
  • IL-23
  • IL-1
  • IL-5
  • IL-6
  • Others
4.2. Global Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Asthma
  • Inflammatory Bowel Disease (IBD)
  • Others
4.3. Global Biosimilar Interleukins Market, Segmentation by Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Clinics
  • Research Institutes
5. Biosimilar Interleukins Market Regional and Country Analysis
5.1. Global Biosimilar Interleukins Market, Split by Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Biosimilar Interleukins Market, Split by Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Biosimilar Interleukins Market
6.1. Asia-Pacific Biosimilar Interleukins Market Overview
6.2. Asia-Pacific Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Biosimilar Interleukins Market
7.1. China Biosimilar Interleukins Market Overview
7.2. China Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Biosimilar Interleukins Market
8.1. India Biosimilar Interleukins Market Overview
8.2. India Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Biosimilar Interleukins Market
9.1. Japan Biosimilar Interleukins Market Overview
9.2. Japan Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Biosimilar Interleukins Market
10.1. Australia Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Biosimilar Interleukins Market
11.1. Indonesia Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Biosimilar Interleukins Market
12.1. South Korea Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Biosimilar Interleukins Market
13.1. Western Europe Biosimilar Interleukins Market Overview
13.2. Western Europe Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Biosimilar Interleukins Market
14.1. UK Biosimilar Interleukins Market Overview
14.2. UK Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Biosimilar Interleukins Market
15.1. Germany Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Biosimilar Interleukins Market
16.4. France Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Biosimilar Interleukins Market
17.1. Eastern Europe Biosimilar Interleukins Market Overview
17.2. Eastern Europe Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Biosimilar Interleukins Market
18.1. Russia Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Biosimilar Interleukins Market
19.1. North America Biosimilar Interleukins Market Overview
19.2. North America Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Biosimilar Interleukins Market
20.1. USA Biosimilar Interleukins Market Overview
20.2. USA Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Biosimilar Interleukins Market
21.1. South America Biosimilar Interleukins Market Overview
21.2. South America Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Biosimilar Interleukins Market
22.1. Brazil Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Biosimilar Interleukins Market
23.1. Middle East Biosimilar Interleukins Market Overview
23.2. Middle East Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Biosimilar Interleukins Market
24.1. Africa Biosimilar Interleukins Market Overview
24.2. Africa Biosimilar Interleukins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Biosimilar Interleukins Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Biosimilar Interleukins Market Competitive Landscape and Company Profiles
25.1. Biosimilar Interleukins Market Competitive Landscape
25.2. Biosimilar Interleukins Market Company Profiles
25.2.1. MabPharm
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Gedeon Richter
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Bio-Thera Solutions
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Sorrento Therapeutics/MabTech
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Sunshine Guojian Pharmaceutical
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers and Acquisitions in the Biosimilar Interleukins Market

27. Biosimilar Interleukins Market Trends and Strategies

28. Biosimilar Interleukins Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bio-Thera Solutions
  • Gedeon Richter
  • MabPharm
  • MORE
Major players in the biosimilar interleukins market are MabPharm, Gedeon Richter, Bio-Thera Solutions, Sorrento Therapeutics/MabTech and Sunshine Guojian Pharmaceutical.

The global interleukins market is expected to grow from $0.83 billion in 2019 to $1.6 billion in 2020 at a compound annual growth rate (CAGR) of 93.0%. The slow growth despite being launched in 2019 is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $5.81 million in 2023 at a CAGR of 53.64%.

The biosimilar interleukins market consists of sales of interleukin biosimilars generated by the establishments that manufacture interleukin biosimilars that are used to treat various autoimmune diseases. Interleukin is a substance derived from white blood cells that enhances infection activity and is used to fight certain types of cancer.

North America was the largest region in the interleukins market in 2019.

In January 2020, Sanofi, a France-based pharmaceutical company, acquired Synthorx, Inc. for $2.5 billion. This acquisition enhances Sanofi’s position as an emerging leader in the area of oncology and immunology. Synthorx, Inc. is a US-based biotechnology company focused on developing interleukins for people suffering from cancer and autoimmune disorders.

The biosimilar interleukins market covered in this report is segmented by type into IL-17; IL-23; IL-1; IL-5; IL-6; others. It is also segmented by application into psoriasis; psoriatic arthritis; rheumatoid arthritis; asthma; inflammatory bowel disease (IBD); others and by distribution channel into hospital pharmacies; online pharmacies; retail pharmacies; clinics; research institutes.

The regulatory framework around the approval of interleukin biosimilars hampers the growth of the market. Biosimilars are manufactured with changes in the manufacturing process impacting the physicochemical and functional properties of a biologic drug and it is impractical to create an exact copy of the biologic drug. This compels the manufacturers to demonstrate biosimilarity between interleukin biosimilar and the biologic drug to prove that there are no clinically meaningful differences. This calls for extensive comparative analytical, nonclinical, and clinical assessments to get approval from the medical authorities, thereby, increasing the cost of the approval process and restraining the growth of the market.

The increasing prevalence of autoimmune diseases such as psoriasis and rheumatoid arthritis is expected to boost the growth of the interleukin biosimilars market in the forecast period. Autoimmune disorders are conditions in which the immune cells cannot distinguish healthy cells from potentially dangerous antibodies. Biologic drugs such as anti-interleukin antibodies have shown significant clinical benefit in regulating the cells, and in directing proliferation, activation, and migration of the cells. According to the British Society for Immunology report 2018, many autoimmune disorders showed a year-on-year increase in incidence at rates between 3% and 9%. In the US, there were 7.4 million people affected with psoriasis in 2017 and this number is ever increasing. Therefore, the increasing prevalence of autoimmune diseases is increasing the demand for the biosimilar interleukins market and is expected to drive the growth of the market.
Note: Product cover images may vary from those shown
  • MabPharm
  • Gedeon Richter
  • Bio-Thera Solutions
  • Sorrento Therapeutics/MabTech
  • Sunshine Guojian Pharmaceutical
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll